Welcome to Cochlear ProNews, your source for professional news that allows you to stay up to date on the latest research and hot topics in the hearing industry. Content includes surgical insights, clinical conversations, AudiologyOnline opportunities and peer-to-peer material. Also, don’t miss out on important information about our services and products such as the Nucleus® 7, Kanso® 2, Baha® 6 Max and Osia® Sound Processors. Subscribe now!
Featured posts
Case study: Intraoperative correction of a CI632 placement using the Nucleus® SmartNav System and TransImpedance Matrix recording
By Nauman F. Manzoor, M.D. * and Viral Tejani, Au.D., Ph.D. * Department of Otolaryngology-Head and Neck Surgery, University Hospitals / Case Western Reserve University School of Medicine *Co-authors with equal contribution to the write-up Patient background An 88 year old female was referred for bilateral progressive sensorineural hearing loss and remote history of left- sided Meniere’s Disease. She no longer had […]
FDA approves Cochlear Nucleus Implants for unilateral hearing loss/single-sided deafness
Individuals with UHL/SSD can now seek treatment with a cochlear implant from Cochlear to hear with both ears Lone Tree, Colo. (January 11, 2022) — Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval of CochlearTM Nucleus® Implants for the treatment of unilateral hearing loss (UHL)/single-sided deafness (SSD). Cochlear implants are already […]
Reliability reporting with Madison Sakaan, AuD
Madison Sakaan, Cochlear Implant Program Director at Johnson Audiology, describes the importance of reliability and reliability reporting from a clinician’s perspective. Tell us a little bit about yourself, Dr. Sakaan. What’s your favorite part about being an audiologist? I have been with Johnson Audiology in Chattanooga, Tennessee for just over two years. I received my Doctorate degree from East Tennessee State University […]
All posts
Osia implant hearing rehabilitation in a patient with a chronically draining mastoid cavity
By Andrew J. Ebelhar, MD The chronic mastoid cavity can present an additional obstacle for implantable hearing device rehabilitation of […]
2021 Annual Reliability Report
Cochlear is proud to share our 2021 Annual Reliability Report. With more than three decades of reporting on reliability, our […]
Identifying upgrade eligible patients with Custom Sound Pro
By Kyle Longwell, Product Manager – Software and Clinical Care We know one of the most exciting things about Cochlear […]
Inclusivity in video games
By Kathryn Tribulski, AuD Why those with hearing loss can be left behind in the video game world Below is […]
Case study: Intraoperative correction of a CI632 placement using the Nucleus® SmartNav System and TransImpedance Matrix recording
By Nauman F. Manzoor, M.D. * and Viral Tejani, Au.D., Ph.D. * Department of Otolaryngology-Head and Neck Surgery, University Hospitals […]
Considerations for a healthy marketing plan
By Regina Presley, AuD, FAAA, CCC-A, Director of Audiology at the Presbyterian Board of Governors Cochlear Implant Center of Excellence […]
Research spotlight with Dr. Julia Drouin: Leveraging Auditory Training to Optimize Cochlear Implant Adaptation
This Q&A with Dr. Julia Drouin, AuD, PhD, explores highlights from her related article, Leveraging interdisciplinary perspectives to optimize auditory […]
Q&A with Dr. Scott Brown: SSD and the reimbursement landscape
By C. Scott Brown, MD, Neurotologist & Lateral Skull Base Surgeon at the Atlanta Institute for ENT Although the recent […]
SSD/UHL treatment considerations: Q&A with Camille Dunn, AuD
By Camille C. Dunn, PhD, CCC-A, Assistant Research Professor, Director, University of Iowa Cochlear Implant Program Department of Otolaryngology—Head and […]
An inside look at the 2022 NYU Fellows Lab
As part of our commitment to provide best in class training and support to our professionals, we recently hosted a […]
Cochlear Americas recognizes Lisa Aubert as new President for the region
Company thanks outgoing President Tony Manna for his years of service, congratulates him on retirement Cochlear Limited (ASX: COH), the […]
Cochlear expands treatment options for individuals with single-sided deafness
By Ryan Lopez, Director, Nucleus Product Management & Marketing In January 2022, Cochlear received FDA approval to treat patients with […]